Lung adenocarcinoma (LUAD), originating in alveolar type 2 epithelial cells, is the most common histological subtype of NSCLC [4], with KRAS the most frequently mutated oncogenic driver, found in ~ 30% of cases [5]. Here, KRAS is linked to non-small cell lung carcinoma.